PMID: 6983562Dec 1, 1982Paper

Human T cell hybridomas secreting factors for IgA-specific help, polyclonal B cell activation, and B cell proliferation

The Journal of Experimental Medicine
L MayerH G Kunkel

Abstract

Human T-T hybridomas were established by fusion of concanavalin A-activated OKT-4+ T cells with hypoxanthine guanine phosphoribosyl transferase-deficient as well as nondeficient T cell lines. Four hybrids were selected for further study. Supernatant from hybrid clone J1.3 specifically enhanced IgA production and secretion by isolated human B cells, with increases in IgA plaque-forming cells approaching those seen with addition of autologous T cells and pokeweed mitogen. A monoclonal lymphocytic leukemia with membrane IgA also differentiated to IgA plasma cells by this supernatant. Evidence suggests that this hybrid supernatant acts on post-switch IgA-committed B cells. The other hybrids were not isotype specific; hybrid J2S1 enhanced polyclonal Ig secretion and hybrids K1 and K8 induced B cell proliferation without induction of Ig secretion.

References

Mar 1, 1979·The Journal of Experimental Medicine·C O ElsonW Strober
Apr 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·J Anderson, F Melchers
Dec 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·M OkadaT Kishimoto
Jan 1, 1981·The Journal of Experimental Medicine·P K MonginiW E Paul
Aug 27, 1981·Nature·C Grillot-CourvalinA Bernheim
Nov 1, 1981·The Journal of Experimental Medicine·B SredniW E Paul
Dec 1, 1981·The Journal of Experimental Medicine·O IrigoyenL Chess
Mar 1, 1982·The Journal of Experimental Medicine·P C IsaksonP H Krammer

❮ Previous
Next ❯

Citations

Jan 1, 1994·Cell Motility and the Cytoskeleton·L SperlingM Wright
May 1, 1989·Journal of Clinical Immunology·J R McGheeH Kiyono
Sep 1, 1984·Journal of Clinical Immunology·A MuraguchiA S Fauci
Jan 1, 1984·Disease-a-month : DM·J Laurence
Feb 28, 1985·Journal of Immunological Methods·N KouttabA L Maizel
Aug 2, 1985·Journal of Immunological Methods·L MayerH G Kunkel
Jun 24, 1991·Journal of Immunological Methods·A ShakedL Mayer
Jan 21, 1992·Journal of Immunological Methods·A BettinardiD Primi
Mar 1, 1990·Veterinary Immunology and Immunopathology·J O Olobo, S J Black
Nov 17, 1986·Immunology Letters·L WalkerG D Johnson
Nov 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·R J NoelleE S Vitetta
Feb 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·F GostiM Bornens
Sep 1, 1983·The Journal of Experimental Medicine·R D BiglerH G Kunkel
Sep 1, 1984·The Journal of Experimental Medicine·D M SpaldingJ R McGhee
Nov 1, 1984·The Journal of Experimental Medicine·L K JungS M Fu
Dec 1, 1984·The Journal of Experimental Medicine·J E LaytonP H Krammer
Jan 1, 1985·The Journal of Experimental Medicine·L MayerH G Kunkel
Sep 1, 1993·The Journal of Experimental Medicine·A PanjaL Mayer
Feb 21, 2014·Mucosal Immunology·C O ElsonS A Lira
Apr 1, 1984·Immunological Reviews·S Bergstedt-LindqvistE Severinson
Apr 1, 1984·Immunological Reviews·G J Prud'hommeA N Theofilopoulos
Jan 1, 1987·Scandinavian Journal of Infectious Diseases. Supplementum·H Schønheyder
Jan 1, 1989·Immunological Investigations·J L Ebersole, M J Steffen

❮ Previous
Next ❯

Related Concepts

Related Feeds

B cell Activation

B cell activation is initiated by the ligation of the B cell receptor with antigen and ultimately results in the production of protective antibodies against potentially pathogenic invaders. Here is the latest research.

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.